calyxlaw 

RECENT APPEARANCES:​

​​

• Presenter, The Therapeutic Use of Psychedelic Drugs (slides; video), American Univ. WCL Symposium, April 12, 2024

• Panelist, Emerging Fields in Law Practice, UC Law SF, Small-to-Midsize Firm Week, Feb. 26, 2024

• Podcast Guest, Navigating the Path to Legalization with Graham Pechenik, Psychedelic Healing, Jan. 10, 2024

• Panelist, Decrim, Gifting & Gray Markets: What Every Business Owner Needs to Know, reMind Forum, Nov. 28, 2023

• Guest Speaker, Employer Spotlight: Graham Pechenik from Calyx Law, UW–Madison PPI Program, Nov. 14, 2023

• Podcast Guest, AI in Drug Discovery & Natural Products Chemistry, How to Launch an Industry, Oct. 18, 2023

• Podcast Guest, Psychedelic Patents & Legalities, The Mindfulness Experience, July 7, 2023

• Panelist, The Psychedelics Business Landscape: Are Companies Faltering or Failing...?, Chacruna, June 28th, 2023

• Moderator, Patents, Commons, & Innovation in Psychedelic Drug Development, PS23, June 23, 2023

• Panelist, Law & Ethics: Opening Our Toolbox for Ethical IP, Part 2 of PBA Four-Part Series, June 20, 2023

• Podcast Guest, The Psychedelic Patent Puzzle, The Psychedelic Podcast by Third Wave, May 22, 2023

• Presenter, Psychedelic Patents: Avoiding Controversy While Achieving Defensible and Enforceable IP, May 16, 2023

• Podcast Interviewee, Law360 Explores: Psychedelics, May 15, 2023

• Workshop Leader (with G. Dwulet), Psychedelics & Patents: Different Views Through the Looking-Glass, May 14, 2023

• Moderator, Equity & Inclusion in the Psychedelic Community, Entheo Society, April 29, 2023

• ​Panelist, Psychedelic Intellectual Property Roundtable Series: Part 1, H.C. Wainwright & Co., April 17, 2023

• Panelist (Chris Byrnes), Thinking Beyond Utilitarianism, Race + IP Conference, April 15, 2023

• Panelist, Building an Equitable Psychedelic Medicines System, SXSW, March 10, 2023

• Presenter, Dead on Arrival? Discussion With an Expert on Psychedelic Medicine IP, EF Hutton, Feb. 27, 2023

• Podcast Guest, Patents, Regulations & REMS...Oh my!, Your Brain on Science, Jan. 31, 2023

• Podcast Guest, Patent Law & Psychedelics, Two Brad for You, Jan. 31, 2023

• Presenter, Legal & Regulatory Landscape for Psychedelics: Protecting IP, TSG Live Webcast, Jan. 12, 2023

• Panelist (with C. Alvarez), Incentives, Investment, & Innovation: Optimizing for Success, Wonderland, Nov. 4, 2022

• Lecturers (C. Byrnes, G. Pechenik & C. Alvarez), IP, Sacred Plants & Indigenous Rights, Chacruna, Oct. 10, 2022

• Panelist, Navigating the Controversial IP Landscape, Microdose Psychedelic Capital, Sept. 29, 2022

• Panelist, Psychedelic Pasts, Presents, & Futures, UW-Madison Borghesi-Mellon Roundtable, Sept. 27, 2022

• Podcast Guest, Psychedelic Patents & Law, Psychoactive with Ethan Nadelmann, Sept. 21, 2022

• Guest Lecturer, Who Owns the Healing Power of Psychedelics?, Instituto Phaneros, Sept. 13, 2022

• Presenter, Promoting Innovation & Ethically Protecting IP, Psychedelic Law Summit, Sept. 8, 2022

• Panelist, Overcoming Roadblocks: Making Psychedelic-Assisted Therapy a Reality, ICPR, Aug. 31, 2022

• Podcast Guest (Chris Byrnes), End of the Road: Episode 235, Michael Kokal, August 29, 2022

• Moderator, Who Put the DEA in Charge of Psychedelic Regulation..., Chacruna, August 19, 2022

• Guest Lecturer, Decriminalization, Legalization & Future of Psychedelics, Stanford LAW107W, Aug. 11, 2022

• Webinar Guest, Psychedelic Patenting, California Psychedelic Bar Association, August 7, 2022

• Moderator, Indigenous Knowledge & Patent Law Roundtable, Porta Sophia ARN Kickoff, June 3, 2022

• Panelist, Psychedelic Capitalism...Creating a Regenerative Renaissance, Plant Spirit Summit, May 27, 2022

• Presenters (with C. Alvarez), IP, Traditional Knowledge, & Open Science, CIIS Guest Lecture, April 25, 2022

• Panelist, EU Psychedelics Legalization & Legislation, Plant Medicine Week Conference, April 7, 2022

• Panelists, Groovy or Square? Patenting Psychedelics, Pot & Plant Medicines, ACS Spring, Mar. 20, 2022

• Podcast Interviewee, Set & Setting: Part II, Maia Laperle, March 2, 2022

• Presenter, LSD IP: Tripping Over the Patent Landscape?, Microdose: LSD Conference, Feb. 17, 2022

• Host, Equity & Public Participation in Psychedelic Patents: with Priti Krishtel, Chacruna, Feb. 16, 2022

• Presenter, Legal & Regulatory Landscape for Psychedelics: Protecting IP, TSG Live Webcast, Jan. 26, 2022

• Panelists, Everything You Ever Wanted To Know About Psychedelic Patents and IP, Jan. 19, 2022

• Presenter, Can We Have a Psychedelic Patent System?, Horizons NYC, Dec. 4, 2021

• Panelist, Patent Wars, Microdose Wonderland Conference, Miami, Nov. 9, 2021

• Presenter, Patents, Ownership, & Commercialization, Int'l Psilocybin Symposium, Sept. 21, 2021

• Panelist (Chris Byrnes), Psychedelic Patents May be Bad for Your Health, Chacruna, Sept. 15, 2021

• Presenter, Psychedelic Patents: Tripping Over a New Patent Landscape?, CLE Comp., Sept. 13, 2021

• Panelist, Psychedelic Ethics: Patents, Patients & DMT, Microdose: DMT Conference, Sept. 10, 2021

• Panelist, Intellectual Property in Psychedelic and Alternative Medicine, Chacruna, Sept. 1, 2021

• Presenter, Cannabis IP—All You Need to Know, Plants to Plants Webinar Series, Aug. 31, 2021

• Interviewee, The Forefront of Cannabis Business 2022 (forthcoming documentary), Aug. 28, 2021

• Presenter, What a Long Strange (Legal) Trip It’s Been, SF Bar Assoc., August 17, 2021

• Presenter, IP in Psychedelics & Oregon’s Psilocybin Services Act, Oregon State Bar, Aug. 3, 2021

• Presenter, Exploring Therapeutic Uses of Psychedelic Substances, Am. Bar Assoc., July 27, 2021

• Podcast Guest, Vine Ventures, July 6, 2021

• Presenter, IP in the Business of Cannabis & Psychedelics, American Chemical Soc'y, June 7, 2021

• Panelist, Psychedelic Monopoly: Patenting & Ownership, Psych. Soc’y UK, Chacruna, May 18, 2021

• Panelist, Patenting Psychoactives, LSPN Connect, May 13, 2021

• Podcast Guest, Analyzing the Atai Life Sciences IPO, Business Trip, May 7, 2021

• Panelist, What’s Next for Cannabis, Hemp, & Psychedelics?, CannaLaw Summit, May 6, 2021

• Podcast Guest, Psychedelic Intellectual Property, Living Mirrors, April 27, 2021

• Moderator, The Past, Present, & Future of Psychedelics, Planet MicroCap Showcase, April 20, 2021 

• Podcast Guest, The IP of Consciousness, How to Launch an Industry, April 9, 2021 

• Panelist, Ethical IP for Psychedelics?, Microdose Psychedelic Insights, March 31, 2021

• Panelist, Awakening: An Exploration of Plant Medicine, Plant Media Project, Dec. 9, 2020

• Panelist, Patent Law for Psychedelic Medicine, Business Trip, Dec. 9, 2020

• Presenter, Psychedelic-Assisted Therapy Meets Patent Rights, Nat’l Academy CLE, Nov. 25, 2020

• Panelist, Mushroom Masterclass: Law & Regulation, Microdose Psych. Insights, Nov. 20, 2021

• Podcast Guest, Graham Pechenik, the Founder of Calyx Law, The Vine, Episode #13, Nov. 12, 2020 

• Podcast Guest, Who Owns Psychedelics, New Amsterdam Psychedelic Law, Nov. 4, 2020

​

RECENT COVERAGE:

​

• Quoted, Big Money Is Taking Over MDMA-Assisted Therapy, Jacobin, Feb. 24, 2024

• Included, 30 Psychedelics Executives, Scientists & Influencers to Watch in 2024 and Beyond, Benzinga, Jan. 10, 2024

• Cited, Decriminalizing Psychedelics: Should Hallucinogenic Drugs Be Legalized?, CQ Researcher, Dec. 15, 2023

• Quoted, Psychedelic Drugs: Follow the Biotech, Venture Capital Money, SJ Mercury News, Dec. 12, 2023

• Quoted, New Psychedelic-Like Drugs: All treatment, No Trip?, SiliconValley.com, Dec. 12, 2023

• Included, reMind Puts the Focus on Psychedelic Small Businesses and Nonprofits, Lucid News, Nov. 10, 2023

• Quoted, This Week in Psychedelics:...MindMed Patents, The Microdose, Nov. 3, 2023

• Quoted, US Patent for 3D Movement Data Goes to RLH Subsidiary, More AI Innovation Ahead, Benzinga, Oct. 20, 2023

• Quoted, California Nixes a Bill to Decriminalize Plant-Based Psychedelics, WIRED, Oct. 9, 2023

• Included, Psychedelics Business Forum reMind Returns To Las Vegas, Forbes, Sept. 22, 2023

• Discussed, Psychedelic Patents, Tripsitter, Aug. 28, 2023

• Quoted, Magic Mushrooms are for Sale in SF, and the City Government has No Idea What to Do, SF Gate, Aug 7, 2023

• Quoted, Evangelist for Legalizing MDMA Therapy Wrestles...as Psychedelics Go Pharma, STAT News, June 29, 2023

• Quoted, Dispatches from Denver: Day 4 at Psychedelic Science 2023, The Microdose, June 23, 2023

• Quoted, Psychedelics Companies Face Quandary In Protecting IP, Law360, May 16, 2023

• Quoted, What’s the Future of Psychedelic Intellectual Property?, Lucid News, March 3, 2023

• Quoted (Chris Byrnes), Do Psychedelics Demand an Innovative Approach to Patents?, Lucid News, March 2, 2023

• Quoted, With a Patent Application, St. Joseph's Univ. Lab Looks To invent..., The Philadelphia Inquirer, Feb. 27, 2023

• Cited, Industry Report: Controversies Surrounding Psychedelic Patents, Water Tower Research, Feb. 2, 2023

• Quoted, Mindset Granted Patent for Lead Drug (But Reunion Also Has Patent), Microdose, Jan. 20, 2023

• Quoted, Psychedelics Are Surging—at the Expense of Indigenous Communities, Daily Beast, Dec. 24, 2022

• Included, The Best Cannabis Lawyers in San Francisco, CNBS, Dec. 7, 2022

• Quoted, Dawn of Decentralized Science, Under the Palm, Nov. 18, 2022

• Quoted (Chris Byrnes), A Look at Web3 and Psychedelic IP, Microdose, Oct. 13, 2022

• Included, Beyond Michael Pollan: Where to Learn More About Psychedelics, Marc Gunther, Sept. 19, 2022

• Included, World Class Leaders in Psychedelics Form Benzinga’s Psychedelic…, Benzinga, Aug. 30, 2022

• Quoted, The Drug Enforcement Agency Listens to Psychedelic Experts, Drug Science, Aug. 5, 2022

• Quoted (Celeste Alvarez), This Week in Psychedelics: Patent Ping Pong, Microdose, July 29, 2022

• Quoted, Special Report: Inside the Challenge to DEA's Proposed Scheduling, Psych. Alpha, July 29, 2022

• Quoted, DEA Reverses Scheduling of Five Novel Psychedelic Compounds, Psych. Today, July 28, 2022

• Quoted, Psychedelic Rx: Legal Battles Aim to Expand Patients' Access..., ABA Journal, July 27, 2022

• Quoted, The High-Stakes Race to Engineer New Psychedelic Drugs, Wired, July 26, 2022

• Quoted, DEA Revokes Project to Schedule 5 New Psychedelic Compounds, Benzinga, July 25, 2022

• Quoted, DEA Cancels Proposed Ban of Five Psychedelics..., Marijuana Moment, July 25, 2022

• Quoted, Breaking News: DEA Reverses Decision to Ban 5 Psychedelics, Microdose, July 23, 2022

• Quoted, Psychedelics Provide New Frontier For Venture Funding..., Crunchbase, July 19, 2022

• Quoted, The Battle for Psychedelic Patents, Psychedelic Spotlight, July 11, 2022

• Quoted, Compass Pathways Psilocybin Patent Upheld, Psychedelic Spotlight, June 24, 2022

• Quoted, This Week in Psychedelics: “Candyflipping,” a non-hallucinogenic..., The Microdose June 24, 2022

• Quoted, Judges Deny Challenge to Psilocybin Patent, VICE, June 23, 2022

• Quoted, This Week in Psychedelics: Patenting Psilocybin for Cancer Patients, The Microdose, May 27, 2022

• Quoted, Patents In The Psychedelics Space:...Here's What The Experts Say, Benzinga, May 20, 2022

• Quoted, A New Database Seeks to Prevent “Bad” Psychedelic Patents, Lucid News, April 25, 2022

• Quoted, Can the Clever Use of Old Legal Strategies Thwart Psychedelic Monopolies?, VICE, Apr, 14, 2022

• Quoted, The Brave New World of Legalized Psychedelics Is Already Here, The Nation, March 19, 2022

• Quoted, A Complex Patent & Pricing Picture: Regulating Psychedelics, Pharma. Exec., March 9, 2022

• Included, Interested In Psychedelics? 30 Accounts You Should Follow On Twitter, TDR, Feb. 23, 2022

• Quoted, Patent trolls beware! This lawyer is tracking every application..., Vancouver Sun, Feb. 18, 2022

• Profiled, Beware the Psychedelic Patent Trolls: Meet the Lawyer..., The GrowthOp, Feb. 14, 2022

• Quoted, This Week in Psychedelics: A DMT Vape Pen Patent, The Microdose, Feb. 4, 2022

• Quoted, DEA Moves to Outlaw Five Tryptamines, The Microdose, UC Berkeley Newsltr, Jan. 28, 2022

• Quoted, This Week in Psychedelics: Psychedelic Patent Applications, The Microdose, Jan. 14, 2022

• Quoted, Rollups: The Emerging Magic Mushroom Monopoly, The American Prospect, Jan. 10, 2022

• Quoted, Should Psychedelics Be Patented?, Freethink, Dec. 29, 2021

• Quoted, An Infamous Psilocybin Patent Has Just Been Challenged, VICE, Dec. 15, 2021

• Profiled, 5 Questions for Graham Pechenik, The Microdose, UC Berkeley Newsletter, Dec. 13, 2021

• Quoted, The Future of Psychedelics Industry Hinges on Patents, Business Insider, Nov. 19, 2021

• Quoted, Latest Psilocybin Patent Highlights Swirling Battle Over Psychedelics IP, STAT, Oct. 26, 2021

• Quoted, The ‘Shroom Boom’: The Meteoric Rise of the Psychedelic Medicine Industry, STAT Reports

• Quoted, Psychedelic Patents: Nature, IP Law, & Exclusion, Truffle Report, Sept. 22, 2021

• Cited, POPLAR: Harvard’s Psychedelic Law, Policy Initiative, Truffle Report, Aug. 10, 2021

• Quoted, J&J's Janssen Denied Data Protection Rights For Spravato, Benzinga, Aug. 9, 2021

• Quoted, COMPASS Pathways’ Psilocybin Patent Questioned, Psymposia, Aug. 5, 2021

• Cited, Are Psychedelics Legal In The US? A Deep Dive Into The Legal Status, Benzinga, July 20, 2021

• Quoted, Peter Thiel–Backed Startup Trying to Monopolize Astral Plane?, Mother Jones, July 6, 2021

• Quoted, LSD to Treat Food Allergies? Company Receives Patent..., SnackSafely.com, July 5, 2021

• Quoted, Experts Share How a Brewing Fight Could Shape the Future, Business Insider, June 2, 2021

• Quoted, Can LSD Treat Food Allergies? We Don’t Know, But It’s Been Patented, VICE, July 1, 2021

• Quoted, Psychedelic Intellectual Property, Reality Sandwich, May 13, 2021

• Included, 100 Most Influential People in Psychedelics, Psychedelic Invest, May 1, 2021

• Profiled, The 100 Most Influential People in Psychedelics, Psychedelic Invest, April 30, 2021

• Quoted, Psychedelics Experts Discuss the Sector’s Ongoing Patent Debate, April 26, 2021

• Quoted, There’s a Land Grab for Psychedelic Patents, Psychedelic Times, April 19, 2021

• Quoted, Is it Possible to Create an Ethical Psychedelics Company?, VICE, April 6, 2021

• Quoted, Psychedelic Monopoly: A Discussion on the Patent Race, Truffle Report, May 29, 2021

• Cited, These 24 Psychedelic Patents Are Paving Way For Medicine 2.0, Benzinga, March 22, 2021

• Quoted, COMPASS Pathways Is Trying to Patent Psilocybin, Psymposia, March 18, 2021

• Quoted, Psyched: The Patents Dilemma, Benzinga, March 15, 2021

• Quoted, Investors Debating Who Should Own the Future of Psychedelics, VICE, March 10, 2021

• Cited, The Psilocybin Patent Race is On, Real Money, March 6, 2021

• Quoted, The Race to Patent Psychedelics is Just Getting Started, VICE, March 5, 2021

• Quoted, Where Profit-Motives & Psychedelics Meet, The Psychedelic Renaissance, Feb. 27, 2021

• Quoted, Cannabinoids in Focus after GW Pharma Snapped Up, Labiotech.eu, Feb. 18, 2021

• Quoted, Can a Company Patent the Basic Components of Psych. Therapy?, VICE, Feb., 9, 2021

• Quoted, Cannabis Patents Can Protect Intellectual Property, Stratcann, Feb. 5, 2021

• Profiled, Meet G. Pechenik: Cannabis & Psychedelics Patent Attorney, Shoutout LA, Jan. 11, 2021

• Cited, Ethical Concerns about Psilocybin Intellectual Property, ACS Pharmacology, Jan. 1, 2021

• Quoted, Canopy’s GW Pharma Lawsuit Trouble for Extractors, Mugglehead, Dec. 24, 2020

• Profiled, Five Psychedelic Law Firms You Should Have on Your Radar, Psych. Invest, Nov. 13, 2020

• Quoted, COMPASS Continues Attempts to Build Psychedelic Monopoly, Psymposia, Sept. 15, 2020

​

RECENT WRITING:

​​

• Navigating the Psilocybin Legal & Patent Landscape (Rachel Mount & G. Pechenik), Psilocybin SF, Dec. 7, 2023

• Psychedelic Industry Report (contributor), Microdose, Aug. 21, 2022

• Pay-For-Success Contracts: An Open Source Alternative to Psychedelic Patents (Savva Kerdemelidis, Celeste Alvarez, G. Pechenik & Chris Byrnes), Microdose, Aug. 8, 2022

• Letters to the Editor: Save America’s Patent System (contributor), I-MAK, May 24, 2022

• Co-Creating a Psychedelic Commons: A Commoner’s Guide (Chris Byrnes & G. Pechenik), Chacruna, Feb. 14, 2022

• Can We Have a Psychedelic Patent System? (G. Pechenik & Chris Byrnes), MAPS Bulletin Vol. 31, No. 2, Aug. 26, 2021

• Special Report: IP & Patents for the Psychedelic Industry (contributor), Microdose, March 9, 2021

• FRENS: A Generalizable Legal Framework for Fractionalized IP-NFTs (Chris Byrnes), VitaDAO, Feb. 4, 2022